spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  OxyContin 

 HSMN NewsFeed - 3 Feb 2017
Intellipharmaceutics Announces FDA Acceptance for Filing of NDA for Rexista(TM) (oxycodone hydrochloride extended release), an Abuse Deterrent Opioid Analgesic for the Treatment of Moderate to Severe Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Nov 2016
Intellipharmaceutics Submits New Drug Application for Rexista(R) (oxycodone hydrochloride extended release), an Abuse Deterrent Opioid Analgesic for the Treatment of Moderate to Severe Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Feb 2016
Collegium Provides Litigation Update
Biopharmaceuticals Litigation
 HSMN NewsFeed - 3 Dec 2013
Impax Laboratories Announces OxyContin(R) Patent Challenge Settlement
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 17 Jan 2013
Collegium Pharmaceutical Announces Relocation to Massachusetts
Biopharmaceuticals
 HSMN NewsFeed - 17 Dec 2012
Titan Pharmaceuticals Licenses Exclusive Probuphine(R) Commercialization Rights in U.S. and Canada to Braeburn Pharmaceuticals
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 24 Jul 2012
Relmada Therapeutics Raises $3.0 Million In Initial Closing Of Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Oct 2010
Omeros Receives $20 Million from Vulcan Capital and $5 Million Grant Award from Washington State's Life Sciences Discovery Fund to Advance its GPCR Program
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Sep 2008
Purdue Pharma L.P. Announces Resolution of OxyContin(R) Patent Lawsuit with Mallinckrodt Inc.
Biopharmaceuticals Generics Litigation Licensing
 HSMN NewsFeed - 2 Sep 2008
Covidien Announces Agreement with Purdue Pharma L.P. Enabling Launch of Oxycodone Hydrochloride Extended-Release Tablets
Biopharmaceuticals Generics Litigation Licensing
 HSMN NewsFeed - 2 Apr 2007
Purdue Pharma L.P. Announces Agreement to End OxyContin(R) Patent Lawsuit with IMPAX Laboratories
Biopharmaceuticals Generics Litigation Licensing
 HSMN NewsFeed - 2 Apr 2007
IMPAX Settles Oxycontin(R) Litigation; Amends Marketing Agreement with DAVA Pharmaceuticals
Biopharmaceuticals Generics Litigation Licensing
 HSMN NewsFeed - 21 Feb 2007
Javelin Pharmaceuticals Names Derek Gallacher as European Managing Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Dec 2006
Largest Disease Modification Trial for Parkinson's Disease Completes Enrollment
Biopharmaceuticals Neurology
 HSMN NewsFeed - 18 Oct 2006
TEVA Announces Planned Retirement of President & CEO in 2007
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Oct 2006
Teva Announces OxyContin(R) Litigation Dismissed; Settlement with Purdue Finalized
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 16 Oct 2006
Purdue Pharma L.P. Announces Signing of Consent Judgment Ending OxyContin(R) Tablets Patent Lawsuit with Teva Pharmaceuticals
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 12 Oct 2006
Teva Announces Tentative Approval for Generic Risperdal(R) Oral Solution
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 3 Oct 2006
Long-Term Data Demonstrated Significantly Better Patient Adherence to COPAXONE(R) versus Interferons in Multiple Sclerosis Treatment
Biopharmaceuticals Neurology
 HSMN NewsFeed - 2 Oct 2006
COPAXONE(R) Showed Sustained Benefit on Slowing Brain Tissue Damage in Multiple Sclerosis Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 29 Sep 2006
Very Active Multiple Sclerosis Patients Benefited from COPAXONE(R) Treatment Following Short-Term Induction with Mitoxantrone
Biopharmaceuticals Neurology
 HSMN NewsFeed - 29 Sep 2006
Study Showed Significant and Sustained Efficacy Of COPAXONE(R) Alone Following Short-Term Combination Therapy With IV Steroids in Multiple Sclerosis Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 28 Sep 2006
New Data Confirmed Antibodies to COPAXONE(R) do not Impact Its Established and Sustained Long-Term Efficacy in Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 26 Sep 2006
Teva Pharmaceutical Industries Ltd. and Protalix Biotherapeutics Ltd. Announce a Collaboration Agreement for the Development of Two Biopharmaceuticals, Based on Protalix's Recombinant Plant Cell Expression Technology
Biopharmaceuticals Licensing
 HSMN NewsFeed - 20 Jul 2006
Teva Announces Final Approval of Meloxicam Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 12 Jul 2006
Teva Announces Tentative Approval of Generic Lotrel(R) Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 12 Jul 2006
Teva Will Be Sole Promoter of AZILECT(R) for Parkinson's Disease in the United States
Biopharmaceuticals Neurology
 HSMN NewsFeed - 30 Jun 2006
Teva Receives FDA Approval for Generic Zoloft(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 27 Jun 2006
Teva Provides Generic Biaxin(R) XL Update
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 23 Jun 2006
Teva Receives First U.S. Approval of Generic Zocor(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 23 Jun 2006
Teva Announces Novartis' Sandoz Unit Seeks to Delay First FDA Approval of Generic Zocor(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 23 Jun 2006
Endo Receives FDA Approval for Opana(R) ER (oxymorphone HCl) Extended-Release and Opana(R) (oxymorphone HCl) Immediate Release Tablets CII
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Jun 2006
Court of Appeals Rules in Favor of Teva on Biaxin(R) XL Preliminary Injunction
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 31 May 2006
COPAXONE(R) Reduced Relapses and Stabilized Disability as Measured by Expanded Disability Status Scale, When Avonex(R) Failed
Biopharmaceuticals Neurology
 HSMN NewsFeed - 28 May 2006
Teva Announces Tentative Approval for Generic Cozaar(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 25 May 2006
Teva Announces Tentative Approval of Simvastatin Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 22 May 2006
Teva Announces Approval of Generic Lexapro(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 17 May 2006
AZILECT(R) FDA Approval Brings New Hope to People Living With Parkinson's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 17 May 2006
Teva Announces FDA Grants Approval of AZILECT(R) (Rasagiline) for Parkinson's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 8 May 2006
Long-Term Copaxone(R) Study Showed 92% of Multiple Sclerosis Patients Were Still Walking Unaided After a Mean of 10 Years on Treatment
Biopharmaceuticals Neurology
 HSMN NewsFeed - 7 May 2006
Teva Announces Approval of Polyethylene Glycol 3350 NF for Oral Solution
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 5 May 2006
ORADUR(TM) Technology Milestone: Remoxy(TM) (ORADUR-Based Oxycodone) Commences Pivotal Phase III Program
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 70

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 70 additional stories matching:
OxyContin
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.